Unknown

Dataset Information

0

Recent Advances in Targeting ROS1 in Lung Cancer.


ABSTRACT: ROS1 is a validated therapeutic target in NSCLC. In a phase I study, the multitargeted MET proto-oncogene, receptor tyrosine kinase/anaplastic lymphoma kinase/ROS1 inhibitor crizotinib demonstrated remarkable efficacy in ROS1-rearranged NSCLCs and consequently gained approval by the United States Food and Drug Administration and by the European Medicines Agency in 2016. However, similar to other oncogene-driven lung cancers, ROS1-rearranged lung cancers treated with crizotinib eventually acquire resistance, leading to disease relapse. Novel ROS1 inhibitors and therapeutic strategies are therefore needed. Insights into the mechanisms of resistance to ROS1-directed tyrosine kinase inhibitors are now beginning to emerge and are helping to guide the development of new ROS1 inhibitors. This review discusses the biology and diagnosis of ROS1-rearranged NSCLC, and current and emerging treatment options for this disease. Future challenges in the field are highlighted.

SUBMITTER: Lin JJ 

PROVIDER: S-EPMC5659942 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recent Advances in Targeting ROS1 in Lung Cancer.

Lin Jessica J JJ   Shaw Alice T AT  

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20170814 11


ROS1 is a validated therapeutic target in NSCLC. In a phase I study, the multitargeted MET proto-oncogene, receptor tyrosine kinase/anaplastic lymphoma kinase/ROS1 inhibitor crizotinib demonstrated remarkable efficacy in ROS1-rearranged NSCLCs and consequently gained approval by the United States Food and Drug Administration and by the European Medicines Agency in 2016. However, similar to other oncogene-driven lung cancers, ROS1-rearranged lung cancers treated with crizotinib eventually acquire  ...[more]

Similar Datasets

| S-EPMC4263209 | biostudies-literature
| S-EPMC7306856 | biostudies-literature
| S-EPMC6943879 | biostudies-literature
| S-EPMC6206601 | biostudies-literature
| S-EPMC4185902 | biostudies-literature
| S-EPMC3703205 | biostudies-literature
| S-EPMC6311705 | biostudies-literature
| S-EPMC8642057 | biostudies-literature
| S-EPMC8547521 | biostudies-literature
| S-EPMC9354965 | biostudies-literature